← Eichor
Condition: Obese With Comorbidities Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Obese With Comorbidities

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Metformin as Adjunct Therapy in Depression-Obesity Comorbidity: Clinical and Genetic Evaluation
NA · 2 location(s) · Riphah International University · NCT07654179A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Phase 3 · 38 location(s) · Eli Lilly and Company · NCT06672939A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Bea
Phase 2 · 6 location(s) · Aphaia Pharma US LLC · NCT07008456A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07255209Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
Phase 2 · 1 location(s) · Hudson Biotech · NCT07467447Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
NA · 1 location(s) · Kazakh Academy of Nutrition · NCT07728669NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status
NA · 1 location(s) · National Science and Technology Council, Taiwan · NCT07439744Tailored Stapled SADI-S: Initial Report and Preliminary Results
NA · 1 location(s) · El-Sahel Teaching Hospital · NCT07289555Comorbidities Resolution After MGB Surgery and Change in Body Composition
Phase N/A · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06015620Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With We
Phase 3 · 1 location(s) · Hudson Biotech · NCT07481747Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Wh
Phase 3 · 88 location(s) · Kailera · NCT07284875Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Rela
Phase 2 · 36 location(s) · Kailera · NCT07497880A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Phase 3 · 72 location(s) · Eli Lilly and Company · NCT06439277Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
Phase 3 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07279194Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Phase 2 · 21 location(s) · Sun Pharmaceutical Industries Limited · NCT07282743A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Phase 1 · 2 location(s) · Corxel Pharmaceuticals · NCT07652047
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.